ClinicalMetric tracks all active clinical trials for cin3 sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 3 1
Top Sponsors
1 trial
1 trial
1 trial
NCT05413798
Recruiting
Urine HPV Testing for Cervical Cancer Screening Among Women Living With HIV in South Africa
Enrollment
300 pts
Location
South Africa
Sponsor
UNC Lineberger Comprehensive C...
NCT04422366 Phase 3
Recruiting
Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
Enrollment
8,000 pts
Location
China
Sponsor
Shanghai Bovax Biotechnology C...
NCT06147388
Recruiting
Regression of Cervical Precancerous Lesions and Associated Risk Factors
Enrollment
300 pts
Location
Czechia
Sponsor
General University Hospital, P...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology